Raymond James Maintains Strong Buy on DexCom, Raises Price Target to $151
Portfolio Pulse from Benzinga Newsdesk
Raymond James analyst Jayson Bedford has reaffirmed a Strong Buy rating on DexCom (NASDAQ:DXCM) and increased the price target from $147 to $151.
January 23, 2024 | 12:26 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Raymond James analyst Jayson Bedford has maintained a Strong Buy rating on DexCom and raised the price target to $151.
The reaffirmation of a Strong Buy rating and an increase in the price target by a reputable analyst like Jayson Bedford from Raymond James typically signals a positive outlook for the company's stock, suggesting potential short-term price appreciation.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100